top of page
Pembrolizumab

Pembrolizumab, is an immunotherapy used to treat various cancers. Here are the key points:

  • Purpose and Mechanism:

    • Pembrolizumab is an anti-PD-1 therapy that blocks the PD-1 receptor, allowing the immune system to recognize and attack cancer cells.
    • It is used for several cancer types, including:
      • Melanoma
      • Lung cancer
      • Head and neck cancer
      • Hodgkin lymphoma
      • Stomach cancer
      • Cervical cancer
      • Certain types of breast cancer.
  • Administration:

    • Given as an intravenous infusion (IV) in a hospital or clinic.
    • Typically administered every 3 to 6 weeks, depending on the specific cancer type and treatment plan.
  • Warnings and Side Effects:

    • Pembrolizumab can cause serious side effects related to the immune system.
    • Common side effects include skin problems, vision issues, fever, and muscle/joint pain.
    • Frequent medical tests are necessary to monitor safety during treatment.

Remember to consult your doctor for personalized advice. If you have further questions, feel free to ask! 😊

Pembrolizumab

  • Strengths

    25 mg/ml 4ml

  • Container

    Glass Vial

  • Use

    • It is used for several cancer types, including:
      • Melanoma
      • Lung cancer
      • Head and neck cancer
      • Hodgkin lymphoma
      • Stomach cancer
      • Cervical cancer
      • Certain types of breast cancer.
  • Targate

    PD-1

ABOUT

Farbe Firma Pvt Ltd is an innovative pharmaceutical company dedicated to providing the highest quality of medicines to our customers. We strive to be a leader in the industry by continuously innovating our products and services and working hard to develop safe, effective, and affordable treatments for our patients.

  • farbe firma
  • farbe firma
  • farbe firma
  • farbe firma
  • farbe firma
  • Whatsapp
  • farbe firma
  • farbe firma
CONTACT US
QUICK LINKS
PRODUCTS
Plot No 1508 GIDC
Ankleshwar 393002
Gujarat India

+91 915 716 4224
+91 932 797 4224

info@farbefirma.com
© Copyright©
bottom of page